nChroma Bio
Boston
About nChroma Bio
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $75.0M
- Last round: Series Unknown (Dec 2024)
- Website: nchromabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nchroma-bio-20089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.